Vanguard Group »

Elevation Oncology shares owned by Vanguard Group

Quarter-by-quarter ownership of Elevation Oncology (ELEV) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Elevation Oncology

Tip: Access up to 7 years of quarterly data

All positions including Elevation Oncology held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elevation Oncology by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $629k 1.2M 0.54
2023-09-30 $709k 1.1M 0.66
2023-06-30 $1.6M 1.1M 1.52
2023-03-31 $866k 456k 1.90
2022-12-31 $317k 333k 0.95
2022-06-30 $562k 401k 1.40
2022-03-31 $948k 376k 2.52
2021-09-30 $5.1M 655k 7.79
2021-06-30 $832k 60k 13.87